Page 1

Thermo Fisher SCIENTIFIC FOR IMMEDIATE RELEASE Media Contact Information : Sandy Pound Phone : 781-622-1223 E - mail : sandy.pound@thermofisher.com Investor Contact Information : Rafael Tejada Phone : 781-622-1356 E - mail : rafael.tejada@thermofisher.com Thermo Fisher Scientific Reports Second Quarter 2021 Results Exhibit 99.1 WALTHAM , Mass . ( July 28 , 2021 ) - Thermo Fisher Scientific Inc. ( NYSE : TMO ) , the world leader in serving science , today reported its financial results for the second quarter ended July 3 , 2021 . Second Quarter 2021 Highlights • Second quarter revenue increased 34 % to $ 9.27 billion . • Second quarter GAAP diluted earnings per share ( EPS ) increased 59 % to $ 4.61 . Second quarter adjusted EPS increased 44 % to $ 5.60 . • Launched a range of new products including the Thermo Scientific Orbitrap IQ - X Tribrid Mass Spectrometer to advance complex small molecule research , and the Thermo Scientific Helios 5EXL Wafer DualBeam scanning electron microscope to support the development of increasingly smaller and more complex semiconductors . To advance cell analysis research , the Invitrogen Bigfoot Spectral Sorter and the Invitrogen Attune CytPix Flow Cytometer were also launched in the quarter . Announced collaborations with leading academic medical centers including the Mayo Clinic to accelerate the development and adoption of more precise and personalized diagnostics for blood - based cancers ; a new clinical and commercial cGMP cell therapy manufacturing facility at University of California , San Francisco , to advance innovation in cell and gene therapy ; and at the University of California , Davis , a research collaboration to support the rapid scale - up of large cohort studies and clinical research in metabolomics . Continued to expand both our capacity and capabilities to better serve our customers . In the quarter , we brought additional capacity online to support vaccine and therapy production globally and expanded the production of laboratory plastics in North America and Europe . Shortly after the quarter closed , we opened a new plasmid DNA facility in Carlsbad , California to meet rapidly growing demand for plasmid DNA - based therapies and mRNA - based vaccines . Building on our environmental sustainability initiatives , we committed to reach net - zero carbon emissions by 2050 . Adjusted EPS , adjusted operating income , adjusted operating margin and free cash flow are non - GAAP measures that exclude certain items detailed later in this press release under the heading " Use of Non - GAAP Financial Measures . "